uniQure N.V. Files 8-K: Material Definitive Agreement
Ticker: QURE · Form: 8-K · Filed: Jan 8, 2025 · CIK: 1590560
| Field | Detail |
|---|---|
| Company | Uniqure N.V. (QURE) |
| Form Type | 8-K |
| Filed Date | Jan 8, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $17.00, $70.1 m, $80.7 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, regulatory-filing
TL;DR
uniQure signed a big deal, more details to come.
AI Summary
On January 7, 2025, uniQure N.V. entered into a material definitive agreement. The company also reported other events and filed financial statements and exhibits. Specific details of the agreement and financial information were not provided in this initial filing.
Why It Matters
This filing indicates uniQure has entered into a significant agreement, which could impact its business operations, partnerships, or financial standing.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, and the lack of immediate detail necessitates caution.
Key Players & Entities
- uniQure N.V. (company) — Registrant
- January 7, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement uniQure N.V. entered into?
The filing states that uniQure N.V. entered into a material definitive agreement on January 7, 2025, but the specific terms and nature of the agreement are not detailed in this initial 8-K filing.
What other events are reported in this 8-K filing?
Besides the entry into a material definitive agreement, the filing also indicates 'Other Events' and the submission of 'Financial Statements and Exhibits'.
When was this 8-K report filed with the SEC?
This 8-K report was filed with the SEC on January 8, 2025.
What is uniQure N.V.'s principal executive office address?
uniQure N.V.'s principal executive offices are located at Paasheuvelweg 25a, 1105 BP Amsterdam, The Netherlands.
What is the standard industrial classification for uniQure N.V.?
The standard industrial classification for uniQure N.V. is Pharmaceutical Preparations [2834].
Filing Stats: 834 words · 3 min read · ~3 pages · Grade level 10.7 · Accepted 2025-01-08 16:25:20
Key Financial Figures
- $17.00 — m Shares"), at a price to the public of $17.00 per ordinary share. Under the terms of
- $70.1 m — from the Offering will be approximately $70.1 million, or approximately $80.7 million i
- $80.7 million — imately $70.1 million, or approximately $80.7 million if the Underwriters exercise in full th
Filing Documents
- tm252622d1_8k.htm (8-K) — 30KB
- tm252622d1_ex1-1.htm (EX-1.1) — 221KB
- tm252622d1_ex5-1.htm (EX-5.1) — 65KB
- tm252622d1_ex99-1.htm (EX-99.1) — 11KB
- tm252622d1_ex99-1img001.jpg (GRAPHIC) — 4KB
- 0001104659-25-002043.txt ( ) — 568KB
- qure-20250107.xsd (EX-101.SCH) — 3KB
- qure-20250107_lab.xml (EX-101.LAB) — 33KB
- qure-20250107_pre.xml (EX-101.PRE) — 22KB
- tm252622d1_8k_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events On January 8, 2025, the Company issued a press release entitled "uniQure Announces Pricing of its Public Offering." The full text of the press release is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d)Exhibits. Exhibit No. Description 1.1 Underwriting Agreement, dated as of January 7, 2025, by and between the Company and Leerink Partners LLC, as representative of the several underwriters named therein. 5.1 Opinion of Rutgers & Posch N.V. 23.1 Consent of Rutgers & Posch N.V. (included in Exhibit 5.1) 99.1 Press Release of uniQure N.V. dated January 8, 2025 104 Cover Page Interactive Data File (embedded with the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. UNIQURE N.V. Date: January 8, 2025 By: /s/ Jeannette Potts JEANNETTE POTTS Chief Legal and Compliance Officer